Naoko Takebe to Leukemia, Lymphocytic, Chronic, B-Cell
This is a "connection" page, showing publications Naoko Takebe has written about Leukemia, Lymphocytic, Chronic, B-Cell.
Connection Strength
0.901
-
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute. J Clin Oncol. 2022 06 10; 40(17):1949-1957.
Score: 0.779
-
Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia. Leuk Lymphoma. 2015; 56(12):3336-42.
Score: 0.122